Compounded vs Brand-Name Semaglutide (Ozempic & Wegovy): What Patients Actually Need to Know

The Question Behind Every Patient Conversation

If you've researched semaglutide for weight loss, you've almost certainly encountered two very different price points. Brand-name Ozempic or Wegovy, paid out of pocket, can run $1,000 to $1,800 a month. A compounded semaglutide program from a licensed telehealth provider can run as little as $169 a month — sometimes less for microdose protocols.

The natural question is: Are these actually the same thing? And if compounded semaglutide is so much cheaper, what's the catch?

It's a fair question. The honest answer requires a real explanation of what compounding pharmacies are, how they're regulated, why semaglutide became eligible for compounding in the first place, and what to look for so you know you're getting medication that's safe, sterile, and clinically appropriate. This guide is that explanation — written without sales spin, because patients deserve to understand what they're putting in their bodies.

What "Brand-Name Semaglutide" Actually Is

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist developed by Novo Nordisk. It is sold under three brand names in the United States, each FDA-approved for a specific indication:

• Ozempic — approved for type 2 diabetes (subcutaneous weekly injection)
• Wegovy — approved for chronic weight management in adults with obesity or overweight plus a weight-related condition
• Rybelsus — an oral form approved for type 2 diabetes

All three contain the same active molecule. The differences are in dose strengths, indications, and packaging. Wegovy and Ozempic are both delivered via prefilled injector pens; the active ingredient is identical.

Brand-name semaglutide goes through the FDA's New Drug Application process, which means Novo Nordisk submitted clinical trial data demonstrating safety and efficacy for the specific indications on the label. That's the gold standard — and that's also the reason brand-name pricing is what it is. The trials, the manufacturing scale-up, the marketing, and the patent protection all factor into the list price.

What "Compounded Semaglutide" Actually Is

Compounding is the practice of preparing a customized medication for a specific patient based on a prescription from a licensed provider. Pharmacy compounding has existed for as long as pharmacy itself — it's how medications were made before mass manufacturing — and it remains a regulated, important part of modern medicine for situations where commercial drugs don't fit a patient's needs.

Two categories of compounding pharmacies operate in the U.S., and the distinction matters:

• 503A pharmacies compound prescriptions for individual, identified patients. They are regulated by state boards of pharmacy and follow USP <797> standards for sterile compounding.
• 503B outsourcing facilities compound larger batches and are registered with — and inspected by — the FDA. They follow Current Good Manufacturing Practice (cGMP) standards similar to drug manufacturers.

Compounded semaglutide is the same active pharmaceutical ingredient (API) — semaglutide — formulated by a licensed pharmacy from FDA-registered bulk active ingredient sources. It is not a generic (semaglutide has no FDA-approved generic) and it is not "fake" or "research-grade" semaglutide. It is real semaglutide prepared and dispensed under a valid prescription written by a licensed provider after a medical evaluation.

Why Compounded Semaglutide Exists in the First Place

For most of the last few years, semaglutide appeared on the FDA's official drug shortage list. Federal law — specifically Section 503A of the Federal Food, Drug, and Cosmetic Act — explicitly permits licensed pharmacies to compound a drug that is, or has recently been, on the FDA shortage list. This is the legal framework that allows compounded semaglutide to be dispensed.

FDA shortage status changes over time. Patients and providers should consult the current FDA Drug Shortages list and follow guidance from the pharmacy and prescriber regarding which formulations are currently being compounded and under what regulatory pathway.

The point is this: compounded semaglutide isn't a workaround or a gray-market product. It is a regulated category of medication that exists for legitimate reasons — to ensure patients can access medically appropriate therapy when supply or formulation issues make brand-name product impractical.

Is Compounded Semaglutide Safe?

This is the question that matters most, so let's answer it directly: when prepared at an accredited compounding pharmacy by licensed pharmacists who follow USP <797> sterile compounding standards, compounded semaglutide is held to rigorous safety and quality requirements. The variables that determine safety are real, and patients should ask about every one of them.

Here's what to look for and what to ask:

• Is the pharmacy state-licensed and in good standing? Every legitimate compounding pharmacy is licensed by the state board of pharmacy where it operates, and most are licensed in multiple states they ship to. License status is publicly searchable on state board websites.
• Does the pharmacy follow USP <797> for sterile compounding? USP <797> is the official United States Pharmacopeia standard for compounding sterile preparations. It governs everything from cleanroom air quality (ISO Class 5/7), gowning, and beyond-use dating to environmental monitoring. For an injectable like semaglutide, sterile compounding is non-negotiable.
• Is the pharmacy accredited? Accreditation by organizations like the Pharmacy Compounding Accreditation Board (PCAB) — a service of the Accreditation Commission for Health Care — is voluntary, but a strong signal that the pharmacy meets recognized industry standards beyond minimum legal requirements.
• Does each batch have a Certificate of Analysis (CoA)? A Certificate of Analysis is third-party laboratory testing that verifies the identity, potency, and purity of the API and the finished product. Reputable compounders test their bulk semaglutide and their finished vials — and can provide documentation on request.
• Where does the active ingredient come from? Bulk semaglutide API used in compounding must come from FDA-registered facilities. This is a legal requirement, not a marketing claim, and is one of the primary distinctions between legitimate compounding and counterfeit or "research peptide" products that should never be used in humans.

What you should not do is buy "semaglutide" from an unverified online vendor, a peptide-research site, or a foreign reseller without a U.S. prescription. Those products are not the same category as a compounded prescription dispensed by a licensed pharmacy. Cost differences in that gray market are not a story about pricing — they're a story about regulatory shortcuts, and the safety implications are serious.

How Madison Meds Approaches Compounded Semaglutide

Madison Meds is a telehealth platform, not a pharmacy. We connect patients with licensed providers who evaluate medical history, screen for contraindications, and write prescriptions when appropriate. Those prescriptions are filled by U.S.-licensed compounding pharmacies that operate under the regulatory framework described above.

For patients, the practical implications are:

• Every prescription is written after a real provider evaluation — not vending-machine style
• Medication is dispensed by a licensed U.S. pharmacy, shipped directly to your address
• The active ingredient is sourced from FDA-registered facilities
• Pricing is transparent and bundled — your monthly fee covers the consult, medication, and shipping

We've written more about the regulatory and operational details on our How It Works page, and patients can read our full compounded medication disclosure for additional information about what compounded medications are and what they aren't.

The Cost Comparison, Honestly

Cost is the most visible difference between brand-name and compounded semaglutide, and it deserves a clear-eyed look.

The cost difference isn't because compounded semaglutide is "cheaper semaglutide." It's because compounding pharmacies don't carry the cost structure of a global brand — no clinical trial recoupment, no patent royalty, no consumer marketing budget. The molecule is the molecule; the pricing reflects different business models.

Are the Effects the Same?

The active ingredient is identical, so the pharmacology is the same. Patients on a properly dosed compounded semaglutide regimen experience the same mechanism of action — slowed gastric emptying, satiety signaling, and metabolic effects — as patients on Ozempic or Wegovy.

What can differ:

• Dose form and titration: Brand-name pens come in fixed strengths. Compounded prescriptions can be customized — including very low microdose protocols ($125/month at Madison Meds) for patients who do better with a gentler approach. We've written more about that in our piece on microdose GLP-1 therapy.
• Inactive ingredients: Vial-based compounded preparations may have different excipients than the brand pen formulation. For most patients, this is clinically immaterial; for patients with specific sensitivities, your provider can review the formulation.
• Administration: Brand-name uses a prefilled pen. Most compounded preparations are vials with separate syringes — slightly different mechanics, same delivery into subcutaneous tissue.

How to Get Prescribed Semaglutide Online — and What Real Care Looks Like

For patients exploring compounded semaglutide via telehealth, the appropriate process should look something like this:

• Medical intake: A thorough health questionnaire covering medical history, current medications, allergies, family history (especially of medullary thyroid carcinoma or MEN 2), and weight history
• Provider review and licensure: A licensed clinician — physician, nurse practitioner, or physician assistant — reviews your intake and is licensed in your state
• Synchronous or asynchronous consult: Depending on your state's telehealth rules, this may be a video visit or a careful written exchange
• Screening for contraindications: Including personal/family history of medullary thyroid carcinoma, MEN 2, pancreatitis, severe GI disease, pregnancy, and others
• Prescription written and sent to a licensed pharmacy
• Ongoing follow-up: Real GLP-1 care includes dose-adjustment check-ins, side-effect management, and stop criteria — not just monthly auto-shipments

If a service offers semaglutide without any of those steps, that should be a red flag — for both safety and the question of whether you're getting actual medical care.

So Which One Is Right for You?

There is no universal answer. A few honest framings:

Brand-name Wegovy or Ozempic may be the better fit if: you have insurance coverage that meaningfully reduces out-of-pocket cost, you have a strong preference for an FDA-approved finished product, or your prescriber recommends it based on clinical specifics.

Compounded semaglutide may be the better fit if: you are paying cash, you want flexible dosing (including microdose options), and you are working with a credible telehealth provider that uses a U.S.-licensed compounding pharmacy with documented quality standards.

What is not appropriate, regardless of cost, is unprescribed peptide product purchased online, products from non-licensed pharmacies, or any "semaglutide" obtained outside a real prescriber-pharmacy relationship.

A Final Word on E-E-A-T (Experience, Expertise, Authoritativeness, Trust)

Compounded GLP-1 medications are a real category of care — but the category includes excellent operators and bad ones. The distinguishing factors aren't the marketing or the website design. They're the licensure, the pharmacy, the provider relationships, and the willingness of the company to answer questions about exactly what you're getting and from whom. Ask those questions of any provider — including ours.

If you'd like to see how Madison Meds' program works in practice, our semaglutide page has full pricing, provider information, and the patient screening process. Our how it works page walks through the visit and prescription flow.

Compounded medications are not FDA-approved drugs. Individual results vary. A licensed provider will review your medical history before prescribing, and not all patients are appropriate candidates for GLP-1 therapy. This article is for educational purposes and does not constitute medical advice.